Literature DB >> 9043562

Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom.

N D Barber1, R Batty, D A Ridout.   

Abstract

Pharmacists' clinical interventions in a group of British hospitals were counted, and a model to determine factors that affected the intervention rate was developed. All pharmacists who visited patient wards in 27 acute care hospitals recorded their daily ward visits and their clinical interventions during five consecutive days (Monday through Friday) in June 1993. An intervention was defined as any recommendation made with the intent of changing drug treatment. Mixed-model Poisson regression was used to try to explain variations in the intervention rate, defined as the number of physician-accepted interventions divided by the number of occupied-bed days. Possible predictors of intervention rate considered were characteristics of the hospitals, the wards, and the pharmacists. During the study period, 248 pharmacists visited 10,478 beds and proposed 3,501 interventions. Of these interventions, 3371 were accepted, 56 were rejected, and 74 were unresolved. The most frequent reasons for the interventions involved the dose (29%), the need for therapy (21%), the choice of drug (14%), and the route (12%). Ward type, pharmacist grade, and the total time the pharmacist spent on the wards were significant predictors of the intervention rate. To validate the model, data were collected during the same period in 1994; the model predicted the number of interventions within 1 of the actual number in 82% of cases. In a model explaining the factors that affected the rate of physician-accepted pharmacist interventions in acute care hospitals in the United Kingdom, ward type, pharmacist grade, and total time spent on the ward by the pharmacist were significant predictors of the intervention rate.

Entities:  

Mesh:

Year:  1997        PMID: 9043562     DOI: 10.1093/ajhp/54.4.397

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  30 in total

1.  The psychological reactions of children to burn traumata: a review. Part II.

Authors:  P W Breslin
Journal:  IMJ Ill Med J       Date:  1975-12

2.  Prescribing errors in hospital inpatients: their incidence and clinical significance.

Authors:  B Dean; M Schachter; C Vincent; N Barber
Journal:  Qual Saf Health Care       Date:  2002-12

3.  Reducing prescribing error: competence, control, and culture.

Authors:  N Barber; M Rawlins; B Dean Franklin
Journal:  Qual Saf Health Care       Date:  2003-12

4.  Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment.

Authors:  Carmel M Hughes; Siobhan McCann
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

5.  Computer calculated dose in paediatric prescribing.

Authors:  Richard C Kirk; Denise Li-Meng Goh; Jeya Packia; Huey Min Kam; Benjamin K C Ong
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  The incidence of prescribing errors in hospital inpatients: an overview of the research methods.

Authors:  Bryony Dean Franklin; Charles Vincent; Mike Schachter; Nick Barber
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  What constitutes a prescribing error in paediatrics?

Authors:  M A Ghaleb; N Barber; B Dean Franklin; I C K Wong
Journal:  Qual Saf Health Care       Date:  2005-10

8.  Providing feedback to hospital doctors about prescribing errors; a pilot study.

Authors:  Bryony Dean Franklin; Kara O'Grady; Christos Paschalides; Martin Utley; Steve Gallivan; Ann Jacklin; Nick Barber
Journal:  Pharm World Sci       Date:  2007-02-20

9.  The effects of electronic prescribing on the quality of prescribing.

Authors:  Parastou Donyai; Kara O'Grady; Ann Jacklin; Nick Barber; Bryony Dean Franklin
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

10.  Pediatric drug-related problems: a multicenter study in four French-speaking countries.

Authors:  Sonia Prot-Labarthe; Ermindo R Di Paolo; Annie Lavoie; Stefanie Quennery; Jean-François Bussières; Françoise Brion; Olivier Bourdon
Journal:  Int J Clin Pharm       Date:  2012-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.